The intricate relationship between diet, metabolic disorders, and cancer progression has garnered significant attention in recent years. Excessive calorie intake is known to trigger the production of ...

BridgeBio's pipeline assets like encaleret and BBP-418 offer optionality but lack near-term cash flow and face regulatory ...

Early recognition of cognitive decline in primary care allows for improved management of mild cognitive impairment and dementia in aging populations.

According to DelveInsight's analysis, the primary sclerosing cholangitis market is anticipated to grow during the forecast period (2025--2034), driven by the launch of emerging therapies such as LB-P8 ...

The public debate on cannabis is dominated by a tone of normalization—less stigmatization, more freedom of choice. The promise of a "natural" alternative to medicines. Meanwhile, science, although ...

Chicago-based Adtalem Global Education is again changing its name, this time to Covista, to reflect the for-profit college ...

Exxel Pharma is eyeing a listing on the NYSE American to fund human trials for a drug class that has previously struggled to ...

Assisted reproductive technologies (ART) have become an integral component of infertility care worldwide. Alongside their widespread clinical use, growing ...

TFOS DEWS III emphasizes matching dry eye treatments to specific mechanisms such as lipid imbalance, osmolarity, and glycocalyx failure.

Maxim Group LLC acted as the exclusive financial advisor to Polaryx in connection with the direct listing. Gibson, Dunn & Crutcher LLP served as legal advisor and Brownstein Hyatt Farber Schreck, LLP ...

REY] today announced the start of a collaboration with the Department of Pathophysiology and Transplantation of the ...

Acute decompensated heart failure (ADHF) is one of the leading admission diagnoses worldwide, yet it is an entity with incompletely understood pathophysiology and limited therapeutic options. Patients ...